Tower Research Capital LLC (Trc) Vor Biopharma Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,611 shares of VOR stock, worth $1,466. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,611
Previous 5,315
69.69%
Holding current value
$1,466
Previous $11,000
72.73%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding VOR
# of Institutions
70Shares Held
29MCall Options Held
1.8KPut Options Held
100-
Paradigm Biocapital Advisors LP New York, NY6.46MShares$5.88 Million0.57% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$5.79 Million5.32% of portfolio
-
Laurion Capital Management LP New York, NY3.18MShares$2.9 Million0.07% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$2.05 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$1.65 Million0.0% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $34.6M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...